Copy number amplification of the 10q24.32 locus in patients with advanced CRC leads to increased NFKB2 expression and its binding with STAT2, resulting in the activation of the PD‐L1/PD‐1 axis and immune escape by cancer cells. The gene discussed is NFKB2; the disease is cancer.